Role of Trimetazidine in Ameliorating Endothelial Dysfunction: A Review
Endothelial dysfunction is a hallmark of cardiovascular diseases, contributing to impaired vasodilation, altered hemodynamics, and atherosclerosis progression. Trimetazidine, traditionally used for angina pectoris, exhibits diverse therapeutic effects on endothelial dysfunction. This review aims to...
Saved in:
Main Authors: | Yusof Kamisah (Author), Hamat H. Che Hassan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparative study of the anti-ischemic activity of trimetazidine and the compound ALM-802 under conditions of endothelial dysfunction
by: V. V. Barchukov, et al.
Published: (2019) -
Trimetazidine Reduces Cardiac Fibrosis in Rats by Inhibiting NOX2-Mediated Endothelial-to-Mesenchymal Transition
by: Chen X, et al.
Published: (2022) -
Trimetazidine in Heart Failure
by: Hongyang Shu, et al.
Published: (2021) -
Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway
by: Yi Yang, et al.
Published: (2019) -
Amelioration of Endothelial Dysfunction in Diabetes: Role of Takeda G Protein-Coupled Receptor 5
by: Zhengyao Cai, et al.
Published: (2021)